Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference News provided by Share this article Share this article GAITHERSBURG, Md., April 8, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, Treatments, Testing and the Economy virtual conference. Novavax' COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion. Fireside ...